Literature DB >> 17551128

Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection.

John W Mellors, Joseph B Margolick, John P Phair, Charles R Rinaldo, Roger Detels, Lisa P Jacobson, Alvaro Muñoz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17551128     DOI： 10.1001/jama.297.21.2349

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  67 in total

1.  Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression.

Authors:  Julia C Dombrowski; James B Kent; Susan E Buskin; Joanne D Stekler; Matthew R Golden
Journal:  AIDS       Date:  2012-01-02       Impact factor: 4.177

2.  CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads.

Authors:  Amie L Meditz; Joy M Folkvord; Ngan H Lyle; Kristina Searls; Yolanda S Lie; Eoin P Coakley; Martin McCarter; Samantha Mawhinney; Elizabeth Connick
Journal:  J Infect Dis       Date:  2013-10-31       Impact factor: 5.226

3.  Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists.

Authors:  Paul D Baum; Jennifer J Young; Diane Schmidt; Qianjun Zhang; Rebecca Hoh; Michael Busch; Jeffrey Martin; Steven Deeks; Joseph M McCune
Journal:  Blood       Date:  2012-02-27       Impact factor: 22.113

4.  Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden.

Authors:  Stephen R Cole; Sonia Napravnik; Michael J Mugavero; Bryan Lau; Joseph J Eron; Michael S Saag
Journal:  Am J Epidemiol       Date:  2009-12-09       Impact factor: 4.897

5.  Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Authors:  Shehnaz K Hussain; Weiming Zhu; Shen-Chih Chang; Elizabeth Crabb Breen; Elena Vendrame; Larry Magpantay; Dan Widney; Daniel Conn; Mary Sehl; Lisa P Jacobson; Jay H Bream; Steven Wolinsky; Charles R Rinaldo; Richard F Ambinder; Roger Detels; Zuo-Feng Zhang; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-18       Impact factor: 4.254

Review 6.  The potential role of biomarkers in HIV preventive vaccine trials.

Authors:  Ellen Maclachlan; Kenneth H Mayer; Ruanne Barnabas; Jorge Sanchez; Beryl Koblin; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.731

7.  Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.

Authors:  Marcel Wolbers; Abdel Babiker; Caroline Sabin; Jim Young; Maria Dorrucci; Geneviève Chêne; Cristina Mussini; Kholoud Porter; Heiner C Bucher
Journal:  PLoS Med       Date:  2010-02-23       Impact factor: 11.069

8.  Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships.

Authors:  Jianming Tang; Rakhi Malhotra; Wei Song; Ilene Brill; Liangyuan Hu; Paul K Farmer; Joseph Mulenga; Susan Allen; Eric Hunter; Richard A Kaslow
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

9.  Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.

Authors:  Samuel Alizon; Viktor von Wyl; Tanja Stadler; Roger D Kouyos; Sabine Yerly; Bernard Hirschel; Jürg Böni; Cyril Shah; Thomas Klimkait; Hansjakob Furrer; Andri Rauch; Pietro L Vernazza; Enos Bernasconi; Manuel Battegay; Philippe Bürgisser; Amalio Telenti; Huldrych F Günthard; Sebastian Bonhoeffer
Journal:  PLoS Pathog       Date:  2010-09-30       Impact factor: 6.823

10.  Host genetics and HIV-1 viral load set-point in African-Americans.

Authors:  Sadeep Shrestha; Brahim Aissani; Wei Song; Craig M Wilson; Richard A Kaslow; Jianming Tang
Journal:  AIDS       Date:  2009-03-27       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.